Latest CSL Limited Stories
CSL112 Represents a Promising Investigational Therapy That May Fill a Void in Reducing Early Recurrent Cardiovascular Events in Patients Who Have Suffered a Heart Attack KING OF PRUSSIA, Pa.,
Presentations focus on Hizentra flexible dosing regimens and push administration PRAGUE, Oct.
JNC is the Bleeding Disorders Community's Original Golf and Baseball Competition for Kids with Hemophilia and/or von Willebrand disease (VWD) and Their Families PHOENIX, Oct.
KING OF PRUSSIA, Pa., Oct.
bioCSL to take on expanded role in global influenza vaccine industry MELBOURNE, Australia, Oct.
CSL Plasma center openings are on the rise, as is the demand for plasma protein therapies for the treatment of rare and serious diseases. KING OF PRUSSIA, Pa., Oct.
Company further increases global manufacturing capabilities with production expansions of albumin in Australia and plasma intermediates in U.S.
The 140,000-square foot expansion has received regulatory approval from the U.S. Food & Drug Administration. KING OF PRUSSIA, Pa., Sept.
CSL Behring Assists The Jeffrey Modell Foundation and National Association of School Nurses to prepare an information blitz to improve early referral and diagnosis. KING OF PRUSSIA, Pa., Aug.
Findings presented at the 2014 World Transplant Congress SAN FRANCISCO, July 30, 2014 /PRNewswire/ -- A study presented at the 2014 World Transplant Congress evaluated the safety and
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.